Drug class
Imidazole azole antifungal; ergosterol-biosynthesis inhibitor
Mechanism of action
Inhibits fungal lanosterol 14-alpha-demethylase, disrupting ergosterol synthesis and altering fungal cell-membrane structure and function.
General use cases
- Topical treatment of superficial dermatophyte and yeast skin infections, including tinea pedis, tinea corporis and cutaneous candidiasis, where authorised
- Vaginal formulations may be authorised for vulvovaginal candidiasis in selected markets; route-specific products are not interchangeable
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
